Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of the Natural History of Laminin-Alpha-2-Related Dystrophy (LAMA2-RD) Patients and Identification of Novel Disease Biomarkers

NCT07125040 is registered in ClinicalTrials.gov with Università Vita-Salute San Raffaele as lead sponsor.

NCT NCT07125040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07125040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of the Natural History of Laminin-Alpha-2-Related Dystrophy (LAMA2-RD) Patients and Identification of Novel Disease Biomarkers
Lead sponsor
Università Vita-Salute San Raffaele
Phase
Observational
Overall status
Recruiting
Start date
July 31, 2025
Completion date
May 31, 2028
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lama2-md (merosin deficient congenital muscular dystrophy, mdc1a), lama2-md \(merosin deficient congenital muscular dystrophy, mdc1a\), merosin deficient cmd (full or partial), merosin deficient congenital muscular dystrophy